Fucoidan alone did not significantly decrease the expression of AFP (alpha fetoprotein), a key marker of tumor burden and prognosis, VEGF or VEGFR, although a reduction in their levels was observed in combination with the anti-angiogenic drugs [58]. Here, VEGFA is linked to neoplasm.